TRABECTEDIN

TRABECTEDIN was reported 2350 times

TRABECTEDIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADOLESCENCE 1 0.5000
1 HIGH GRADE SEROUS OVARIAN CARCINOMA 6 0.3158
2 SYNOVIAL SARCOMA METASTATIC 6 0.2500
3 PARANEOPLASTIC HYPOGLYCAEMIA 1 0.2000
4 LYMPHANGIOLEIOMYOMATOSIS 15 0.1376
5 EWING-LIKE SARCOMA 1 0.1250
6 CHILDHOOD 1 0.1250
7 JEJUNECTOMY 4 0.0889
8 LIPOSARCOMA METASTATIC 2 0.0870
9 DESMOPLASTIC SMALL ROUND CELL TUMOUR 7 0.0805
10 AKINAESTHESIA 1 0.0714
11 IMPLANT SITE ULCER 2 0.0690
12 UTERINE LEIOMYOSARCOMA 5 0.0625
13 MEDICAL DEVICE SITE FIBROSIS 3 0.0612
14 SOLITARY FIBROUS TUMOUR 1 0.0588
15 FOLLICULAR DENDRITIC CELL SARCOMA 1 0.0556
16 RETROPERITONEAL INFECTION 1 0.0526
17 LEIOMYOSARCOMA METASTATIC 3 0.0441
18 CEREBRAL HYGROMA 2 0.0435
19 ENDOMETRIAL STROMAL SARCOMA 2 0.0400
20 LEIOMYOSARCOMA RECURRENT 1 0.0385
21 CAROTID ARTERY PERFORATION 1 0.0345
22 INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA 1 0.0345
23 ENZYME ACTIVITY INCREASED 1 0.0312
24 ADMINISTRATION SITE CELLULITIS 1 0.0286
25 CATHETER SITE DERMATITIS 1 0.0278
26 BLOOD ACID PHOSPHATASE INCREASED 1 0.0270
27 IMPLANT SITE THROMBOSIS 1 0.0263
28 CYTOTOXIC CARDIOMYOPATHY 2 0.0244
29 PRODUCT ORIGIN UNKNOWN 1 0.0233
30 ALVEOLAR RHABDOMYOSARCOMA 1 0.0227
31 SARCOMA METASTATIC 3 0.0216
32 INFUSION SITE NECROSIS 4 0.0208
33 BLOOD CREATINE PHOSPHOKINASE 3 0.0205
34 PRODUCT LABEL COUNTERFEIT 1 0.0204
35 SUSPECTED DRUG-INDUCED LIVER INJURY 4 0.0200
36 BLAST CELLS PRESENT 9 0.0187
37 MEAN CELL VOLUME ABNORMAL 8 0.0169
38 NEUTROPHIL PERCENTAGE DECREASED 9 0.0169
39 ANGIOSARCOMA METASTATIC 2 0.0164
40 FOCAL PERITONITIS 1 0.0161
41 LEIOMYOSARCOMA 6 0.0156
42 CAPILLARY PERMEABILITY INCREASED 1 0.0154
43 MALIGNANT FIBROUS HISTIOCYTOMA 2 0.0148
44 CHONDROSARCOMA 2 0.0127
45 INFECTED LYMPHOCELE 1 0.0127
46 SCLEREMA 1 0.0123
47 CAPILLARY LEAK SYNDROME 25 0.0121
48 IMPLANT SITE NECROSIS 1 0.0114
49 ADMINISTRATION SITE INFLAMMATION 1 0.0111
50 INFUSION SITE ULCER 1 0.0109
51 METASTASES TO THYROID 1 0.0109
52 CATHETER SITE RELATED REACTION 8 0.0107
53 CATHETER SITE INFLAMMATION 6 0.0107
54 OVARIAN CANCER METASTATIC 9 0.0106
55 PUTAMEN HAEMORRHAGE 3 0.0105
56 HAEMOGLOBIN 2 0.0101
57 NEUROFIBROSARCOMA 1 0.0097
58 MEDICAL DEVICE SITE THROMBOSIS 1 0.0097
59 MUCOCUTANEOUS TOXICITY 1 0.0095
60 LIPOSARCOMA 3 0.0094
61 CITROBACTER INFECTION 4 0.0093
62 HYPERPHOSPHATASAEMIA 1 0.0091
63 MECHANICAL ILEUS 5 0.0088
64 BILIARY SEPSIS 4 0.0086
65 SOFT TISSUE SARCOMA 3 0.0086
66 NEUROMUSCULAR TOXICITY 3 0.0085
67 CHRONIC RESPIRATORY DISEASE 3 0.0085
68 CANCER FATIGUE 2 0.0084
69 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
70 INADVERTENT INJECTION AIR BUBBLE 1 0.0079
71 TRACHEOBRONCHITIS 6 0.0078
72 COLONIC OBSTRUCTION 2 0.0077
73 FAECAL VOMITING 4 0.0075
74 INTRAUTERINE INFECTION 1 0.0074
75 DUODENITIS HAEMORRHAGIC 1 0.0072
76 HYPERMUTATION 1 0.0071
77 IMPLANT SITE INFLAMMATION 2 0.0068
78 BANDAEMIA 1 0.0068
79 HAEMATOTOXICITY 64 0.0067
80 ABSCESS SOFT TISSUE 1 0.0065
81 HEPATOBILIARY DISEASE 4 0.0064
82 EXTRAVASATION 26 0.0063
83 INJECTION SITE THROMBOSIS 2 0.0061
84 METASTASES TO RETROPERITONEUM 1 0.0059
85 APPLICATION SITE INDURATION 1 0.0059
86 HAEMOGLOBINAEMIA 1 0.0058
87 APLASIA 11 0.0056
88 METASTASES TO MUSCLE 1 0.0055
89 RHABDOMYOSARCOMA 1 0.0053
90 CATHETER SITE VESICLES 1 0.0051
91 DEVICE RELATED THROMBOSIS 5 0.0051
92 BONE MARROW TOXICITY 6 0.0051
93 PSEUDOALDOSTERONISM 1 0.0051
94 PRODUCT QUALITY CONTROL ISSUE 1 0.0049
95 NASAL HERPES 1 0.0049
96 MEAN CELL HAEMOGLOBIN DECREASED 9 0.0049
97 ARTERIAL THROMBOSIS LIMB 2 0.0048
98 MONONEUROPATHY 1 0.0048
99 BLOOD BILIRUBIN ABNORMAL 6 0.0047
100 PNEUMOCOCCAL SEPSIS 3 0.0046
101 SEVERE ACUTE RESPIRATORY SYNDROME 1 0.0045
102 SARCOMA 5 0.0044
103 ANGIOSARCOMA 2 0.0043
104 SUBILEUS 9 0.0043
105 HYPERTRANSAMINASAEMIA 30 0.0043
106 INTUSSUSCEPTION 4 0.0042
107 CLOSTRIDIAL SEPSIS 1 0.0041
108 INFECTED NEOPLASM 1 0.0040
109 ADMINISTRATION SITE EXTRAVASATION 4 0.0040
110 BENIGN LUNG NEOPLASM 1 0.0040
111 TROPONIN T INCREASED 5 0.0039
112 LEFT VENTRICULAR DILATATION 2 0.0039
113 CHEST WALL MASS 1 0.0038
114 NEOVASCULARISATION 1 0.0038
115 HEART FAILURE WITH REDUCED EJECTION FRACTION 2 0.0037
116 CATHETER SITE ERYTHEMA 8 0.0037
117 INFUSION SITE THROMBOSIS 1 0.0037
118 DUODENOGASTRIC REFLUX 1 0.0036
119 RECALL PHENOMENON 3 0.0036
120 ANAEMIA OF MALIGNANT DISEASE 1 0.0036
121 EJECTION FRACTION 2 0.0034
122 CATHETER SITE CELLULITIS 1 0.0034
123 LYMPHATIC DISORDER 2 0.0034
124 NAIL TOXICITY 1 0.0033
125 ENTEROBACTER BACTERAEMIA 1 0.0033
126 CREATININE URINE INCREASED 1 0.0033
127 DEVICE INFUSION ISSUE 8 0.0032
128 CATHETER SITE SWELLING 3 0.0032
129 ONYCHOLYSIS 5 0.0032
130 ARTERITIS 2 0.0032
131 RHABDOMYOLYSIS 132 0.0032
132 KERATOPATHY 5 0.0032
133 OSTEITIS DEFORMANS 1 0.0031
134 ASPERGILLOMA 1 0.0031
135 OVARIAN CANCER RECURRENT 5 0.0031
136 HYPERCREATINAEMIA 1 0.0030
137 MYELOPROLIFERATIVE NEOPLASM 2 0.0030
138 HEPATOTOXICITY 67 0.0030
139 PARANEOPLASTIC SYNDROME 2 0.0030
140 OESOPHAGITIS ULCERATIVE 2 0.0029
141 RHINOCEREBRAL MUCORMYCOSIS 1 0.0029
142 PANCYTOPENIA 161 0.0029
143 TRANSAMINASES INCREASED 64 0.0029
144 CIRCUMORAL OEDEMA 1 0.0029
145 INCORRECT DRUG ADMINISTRATION RATE 12 0.0028
146 LABELLED DRUG-DRUG INTERACTION ISSUE 4 0.0028
147 HYPOALBUMINAEMIA 21 0.0027
148 ACUTE MYELOID LEUKAEMIA 42 0.0027
149 MYOCARDIAL INJURY 3 0.0027
150 NEUTROPENIC SEPSIS 19 0.0027
151 RADIATION OESOPHAGITIS 1 0.0026
152 LYMPHADENOPATHY MEDIASTINAL 5 0.0026
153 HEPATIC MASS 5 0.0026
154 GALLBLADDER PERFORATION 1 0.0026
155 FEBRILE BONE MARROW APLASIA 11 0.0026
156 IMPLANT SITE EXTRAVASATION 2 0.0025
157 LEFT VENTRICULAR DYSFUNCTION 17 0.0025
158 NEUTROPHILIC DERMATOSIS 1 0.0025
159 ACUTE LEUKAEMIA 4 0.0025
160 PERSISTENT DEPRESSIVE DISORDER 1 0.0025
161 FEBRILE NEUTROPENIA 163 0.0025
162 VASOPLEGIA SYNDROME 4 0.0024
163 FISTULA OF SMALL INTESTINE 1 0.0024
164 OVARIAN CANCER STAGE IV 1 0.0024
165 GAMMA-GLUTAMYLTRANSFERASE INCREASED 53 0.0024
166 BLOOD PRODUCT TRANSFUSION DEPENDENT 1 0.0024
167 BLOOD CREATINE PHOSPHOKINASE INCREASED 68 0.0024
168 GLIOSIS 1 0.0023
169 CATHETER SITE PAIN 6 0.0023
170 INFUSION SITE EXTRAVASATION 14 0.0022
171 OESOPHAGEAL INFECTION 1 0.0022
172 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0022
173 RED CELL DISTRIBUTION WIDTH INCREASED 9 0.0022
174 PRIMARY BILIARY CHOLANGITIS 1 0.0021
175 BONE MARROW FAILURE 43 0.0021
176 CRANIAL NERVE PARALYSIS 1 0.0021
177 BLOOD CREATINE ABNORMAL 1 0.0021
178 WRONG PATIENT RECEIVED PRODUCT 6 0.0020
179 NEUTROPHIL COUNT DECREASED 83 0.0020
180 ALANINE AMINOTRANSFERASE INCREASED 125 0.0020
181 METASTASES TO ABDOMINAL CAVITY 1 0.0020
182 CARDIOTOXICITY 18 0.0020
183 ASPARTATE AMINOTRANSFERASE INCREASED 106 0.0020
184 DILATED CARDIOMYOPATHY 2 0.0020
185 ACCIDENT AT HOME 1 0.0019
186 VENOUS THROMBOSIS LIMB 4 0.0019
187 LYMPHANGIOSIS CARCINOMATOSA 2 0.0019
188 NEUTROPENIA 251 0.0018
189 BRONCHOSTENOSIS 1 0.0018
190 DEVICE RELATED INFECTION 28 0.0018
191 THROMBOCYTOPENIA 202 0.0018
192 AZOTAEMIA 7 0.0018
193 TUMOUR HAEMORRHAGE 5 0.0018
194 WOUND INFECTION STAPHYLOCOCCAL 3 0.0017
195 HEPATIC CYTOLYSIS 22 0.0017
196 LEUKOPENIA 86 0.0017
197 HEPATOCELLULAR INJURY 24 0.0017
198 JUGULAR VEIN THROMBOSIS 3 0.0017
199 HEPATORENAL FAILURE 1 0.0017
200 BLOOD ALKALINE PHOSPHATASE INCREASED 41 0.0016
201 EJECTION FRACTION DECREASED 25 0.0016
202 MALLORY-WEISS SYNDROME 2 0.0016
203 PHAEOCHROMOCYTOMA 1 0.0015
204 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
205 ILEAL PERFORATION 1 0.0015
206 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
207 CARBOHYDRATE ANTIGEN 125 INCREASED 5 0.0015
208 PLEURAL THICKENING 1 0.0015
209 BRAIN CANCER METASTATIC 1 0.0014
210 ANGIOPATHY 8 0.0014
211 ACUTE PULMONARY OEDEMA 8 0.0014
212 MUCOSAL INFLAMMATION 37 0.0014
213 BLOOD ALBUMIN DECREASED 11 0.0014
214 CALCULUS URETERIC 1 0.0014
215 DRUG DELIVERY SYSTEM MALFUNCTION 7 0.0014
216 CHOLANGITIS ACUTE 1 0.0013
217 VASCULAR DEVICE INFECTION 6 0.0013
218 OVARIAN NEOPLASM 1 0.0013
219 CREATINE KINASE INCREASED 1 0.0013
220 METASTASES TO LUNG 15 0.0013
221 BLOOD BILIRUBIN INCREASED 35 0.0013
222 ANURIA 11 0.0013
223 VENOUS THROMBOSIS 5 0.0013
224 BLOOD FIBRINOGEN INCREASED 1 0.0013
225 HEPATIC FUNCTION ABNORMAL 47 0.0013
226 ELECTROMECHANICAL DISSOCIATION 1 0.0013
227 PNEUMONIA LEGIONELLA 2 0.0012
228 GASTROINTESTINAL TOXICITY 6 0.0012
229 VENTRICULAR HYPOKINESIA 4 0.0012
230 PELVIC MASS 1 0.0012
231 THROMBOSIS IN DEVICE 4 0.0012
232 HYDROTHORAX 1 0.0012
233 CONGESTIVE CARDIOMYOPATHY 5 0.0012
234 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
235 PYLORIC STENOSIS 1 0.0012
236 NEOPLASM RECURRENCE 4 0.0012
237 DISEASE PROGRESSION 139 0.0012
238 PSEUDOMONAL BACTERAEMIA 1 0.0012
239 APTYALISM 1 0.0012
240 COLONIC ABSCESS 1 0.0012
241 NODAL ARRHYTHMIA 1 0.0012
242 LEFT VENTRICULAR FAILURE 4 0.0012
243 VENTRICULAR DYSFUNCTION 3 0.0012
244 KIDNEY FIBROSIS 2 0.0012
245 CHOLESTASIS 22 0.0011
246 CATHETER SITE PRURITUS 1 0.0011
247 INTESTINAL PSEUDO-OBSTRUCTION 1 0.0011
248 LUNG OPACITY 3 0.0011
249 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2 0.0011
250 GENERALISED OEDEMA 14 0.0011
251 HYPERLEUKOCYTOSIS 1 0.0011
252 BLOOD ALBUMIN INCREASED 1 0.0011
253 ANAEMIA 214 0.0011
254 CANDIDA SEPSIS 1 0.0011
255 COLOUR BLINDNESS 1 0.0011
256 PNEUMONIA KLEBSIELLA 2 0.0011
257 HYPOPHOSPHATAEMIA 8 0.0011
258 BLOOD UREA ABNORMAL 1 0.0011
259 INJECTION SITE ULCER 1 0.0011
260 ASCITES 31 0.0011
261 ELECTROCARDIOGRAM CHANGE 1 0.0011
262 TROPONIN INCREASED 8 0.0011
263 DUODENAL ULCER HAEMORRHAGE 3 0.0010
264 PROSTATE INFECTION 1 0.0010
265 HEPATIC FAILURE 31 0.0010
266 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
267 DUODENAL PERFORATION 1 0.0010
268 COLON ADENOMA 1 0.0010
269 HYPERVOLAEMIA 5 0.0010
270 CELL DEATH 2 0.0010
271 MIXED LIVER INJURY 3 0.0010
272 EMBOLISM VENOUS 3 0.0010
273 DUODENITIS 3 0.0010
274 HYPERURICAEMIA 4 0.0010
275 BLADDER DYSFUNCTION 1 0.0010
276 IMPLANT SITE ERYTHEMA 1 0.0010
277 ANAL PRURITUS 2 0.0010
278 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
279 METASTASES TO PLEURA 1 0.0010
280 NEOPLASM PROGRESSION 33 0.0009
281 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
282 NON-CARDIAC CHEST PAIN 3 0.0009
283 NON-CARDIOGENIC PULMONARY OEDEMA 1 0.0009
284 BLOOD SODIUM ABNORMAL 1 0.0009
285 ACINETOBACTER INFECTION 1 0.0009
286 INFUSION SITE HAEMORRHAGE 3 0.0009
287 OCULAR TOXICITY 1 0.0009
288 GASTROINTESTINAL INFECTION 8 0.0009
289 CATHETER SITE DISCHARGE 1 0.0009
290 KLEBSIELLA SEPSIS 1 0.0009
291 PNEUMONITIS 24 0.0009
292 CARDIOMYOPATHY 13 0.0009
293 METASTASES TO MENINGES 2 0.0009
294 PUPILS UNEQUAL 1 0.0009
295 SICK SINUS SYNDROME 1 0.0009
296 PALMAR ERYTHEMA 1 0.0009
297 OVARIAN CANCER 8 0.0009
298 MACROCYTOSIS 1 0.0009
299 MUCOSAL HAEMORRHAGE 1 0.0009
300 INFUSION SITE INFECTION 2 0.0009
301 IMPLANT SITE INFECTION 2 0.0009
302 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
303 ALLODYNIA 1 0.0009
304 THROMBOPHLEBITIS 3 0.0009
305 PROCALCITONIN INCREASED 1 0.0009
306 PLATELET COUNT DECREASED 90 0.0008
307 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
308 BILE DUCT STENOSIS 1 0.0008
309 EMBOLISM ARTERIAL 1 0.0008
310 MYELODYSPLASTIC SYNDROME 12 0.0008
311 INFLAMMATORY MARKER INCREASED 4 0.0008
312 OLIGURIA 5 0.0008
313 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
314 HEPATIC ENZYME ABNORMAL 4 0.0008
315 NEUROTOXICITY 14 0.0008
316 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
317 METASTASES TO PERITONEUM 2 0.0008
318 SEROMA 1 0.0008
319 MYOCARDITIS 9 0.0008
320 LEFT ATRIAL DILATATION 1 0.0008
321 HEPATIC INFECTION 1 0.0008
322 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
323 ENTERITIS 5 0.0008
324 ENDOCRINE DISORDER 1 0.0008
325 INFUSION SITE IRRITATION 1 0.0008
326 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22 0.0008
327 IATROGENIC INJURY 1 0.0008
328 THERAPY PARTIAL RESPONDER 12 0.0008
329 HEPATITIS TOXIC 2 0.0008
330 PRODUCT PREPARATION ISSUE 5 0.0008
331 BLOOD LACTIC ACID INCREASED 4 0.0008
332 HERPES OPHTHALMIC 1 0.0008
333 SUDDEN DEATH 8 0.0008
334 HIRSUTISM 1 0.0008
335 ABDOMINAL MASS 2 0.0007
336 MUCOUS MEMBRANE DISORDER 1 0.0007
337 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
338 DISCHARGE 1 0.0007
339 CHOLECYSTITIS INFECTIVE 2 0.0007
340 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
341 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
342 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
343 RENAL TUBULAR DISORDER 2 0.0007
344 PRERENAL FAILURE 1 0.0007
345 ALVEOLITIS 1 0.0007
346 FANCONI SYNDROME 1 0.0007
347 AUDITORY DISORDER 1 0.0007
348 BLOOD ELECTROLYTES DECREASED 1 0.0007
349 HAEMATOLOGICAL MALIGNANCY 2 0.0007
350 CEREBELLAR HAEMORRHAGE 1 0.0007
351 ENTEROCOLITIS 4 0.0007
352 ESCHERICHIA SEPSIS 2 0.0007
353 TUMOUR LYSIS SYNDROME 6 0.0007
354 ACUTE ABDOMEN 1 0.0007
355 BACTERAEMIA 8 0.0007
356 INFUSION SITE REACTION 2 0.0007
357 SEPTIC SHOCK 29 0.0007
358 INFERTILITY 1 0.0007
359 INTERSTITIAL LUNG DISEASE 32 0.0007
360 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
361 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
362 MYOGLOBIN BLOOD INCREASED 1 0.0007
363 ACUTE KIDNEY INJURY 100 0.0007
364 INJECTION SITE PARAESTHESIA 1 0.0007
365 ENCEPHALOPATHY 16 0.0007
366 MEAN CELL VOLUME DECREASED 1 0.0006
367 SINUS ARREST 1 0.0006
368 FUNGAEMIA 1 0.0006
369 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
370 INTERMITTENT CLAUDICATION 1 0.0006
371 ATRIAL FLUTTER 5 0.0006
372 SEPSIS 69 0.0006
373 WHITE BLOOD CELL COUNT DECREASED 67 0.0006
374 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
375 MYELOSUPPRESSION 22 0.0006
376 ASPERGILLUS INFECTION 4 0.0006
377 ESCHERICHIA INFECTION 5 0.0006
378 CYTOLYTIC HEPATITIS 2 0.0006
379 PHLEBITIS 3 0.0006
380 CARDIAC FAILURE 47 0.0006
381 BRONCHOPNEUMONIA 2 0.0006
382 INJECTION SITE OEDEMA 1 0.0006
383 PRODUCT COUNTERFEIT 1 0.0006
384 HYPERBILIRUBINAEMIA 6 0.0006
385 BLOOD CREATININE ABNORMAL 2 0.0006
386 SKIN NECROSIS 3 0.0006
387 PSEUDOMONAL SEPSIS 1 0.0006
388 EMBOLIC STROKE 2 0.0006
389 LUNG INFILTRATION 5 0.0006
390 SCLERODERMA 2 0.0005
391 FOOD INTOLERANCE 2 0.0005
392 SINUS NODE DYSFUNCTION 1 0.0005
393 DRUG RESISTANCE 14 0.0005
394 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
395 OTOTOXICITY 1 0.0005
396 STREPTOCOCCAL INFECTION 3 0.0005
397 PROTEIN TOTAL DECREASED 2 0.0005
398 SKIN TOXICITY 3 0.0005
399 BLOOD BICARBONATE DECREASED 1 0.0005
400 MALIGNANT NEOPLASM PROGRESSION 54 0.0005
401 HYPOPROTEINAEMIA 1 0.0005
402 BILE DUCT OBSTRUCTION 1 0.0005
403 PLEURAL EFFUSION 32 0.0005
404 ADRENAL DISORDER 1 0.0005
405 ACUTE HEPATIC FAILURE 7 0.0005
406 METASTASES TO LIVER 9 0.0005
407 BICYTOPENIA 1 0.0005
408 HAEMATOCRIT DECREASED 10 0.0005
409 OESOPHAGEAL CANDIDIASIS 2 0.0005
410 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
411 LYMPHOPENIA 7 0.0005
412 POST PROCEDURAL INFECTION 4 0.0005
413 INJECTION SITE NECROSIS 1 0.0005
414 LIVER INJURY 12 0.0005
415 HEPATIC ENZYME INCREASED 33 0.0005
416 LIVER FUNCTION TEST ABNORMAL 14 0.0005
417 HYPERPYREXIA 2 0.0005
418 LIVER FUNCTION TEST INCREASED 10 0.0005
419 HYPERPHOSPHATAEMIA 1 0.0005
420 LYMPHOCYTOSIS 1 0.0005
421 PERICARDIAL HAEMORRHAGE 1 0.0005
422 HYPOKALAEMIA 21 0.0005
423 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
424 INTESTINAL OBSTRUCTION 17 0.0005
425 PRODUCT LOT NUMBER ISSUE 1 0.0005
426 CARDIAC FAILURE ACUTE 3 0.0004
427 ILEUS PARALYTIC 2 0.0004
428 DRUG-INDUCED LIVER INJURY 14 0.0004
429 MYOSITIS 4 0.0004
430 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
431 COLITIS ISCHAEMIC 3 0.0004
432 URINARY TRACT DISORDER 2 0.0004
433 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
434 DISEASE RECURRENCE 21 0.0004
435 URINE ABNORMALITY 2 0.0004
436 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
437 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
438 AGRANULOCYTOSIS 8 0.0004
439 BILIRUBIN CONJUGATED INCREASED 1 0.0004
440 ESCHERICHIA BACTERAEMIA 1 0.0004
441 HYPOCALCAEMIA 8 0.0004
442 CHOLECYSTITIS 5 0.0004
443 CARDIOGENIC SHOCK 6 0.0004
444 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
445 LONG QT SYNDROME 1 0.0004
446 ACUTE RESPIRATORY FAILURE 8 0.0004
447 APHAGIA 2 0.0004
448 GASTROINTESTINAL OBSTRUCTION 1 0.0004
449 PAINFUL RESPIRATION 1 0.0004
450 RESPIRATORY FAILURE 30 0.0004
451 THROMBOTIC MICROANGIOPATHY 4 0.0004
452 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
453 RENAL TUBULAR NECROSIS 4 0.0004
454 ACUTE MYOCARDIAL INFARCTION 12 0.0004
455 SMALL INTESTINAL OBSTRUCTION 5 0.0004
456 RETINAL TEAR 1 0.0004
457 ORGANISING PNEUMONIA 2 0.0004
458 PULMONARY MASS 6 0.0004
459 ILEUS 5 0.0004
460 HYPERPARATHYROIDISM SECONDARY 1 0.0004
461 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
462 BLOOD CREATININE INCREASED 26 0.0004
463 LYMPHOCYTE COUNT DECREASED 7 0.0004
464 HAEMATEMESIS 10 0.0004
465 ABDOMINAL INFECTION 1 0.0004
466 CANCER PAIN 1 0.0004
467 HYPONATRAEMIA 22 0.0004
468 LUNG INFECTION 6 0.0004
469 PNEUMOTHORAX 6 0.0004
470 RENAL FAILURE 50 0.0004
471 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
472 BLOOD POTASSIUM ABNORMAL 1 0.0004
473 OESOPHAGITIS 4 0.0004
474 EMBOLISM 3 0.0004
475 LIVER DISORDER 16 0.0004
476 SECOND PRIMARY MALIGNANCY 3 0.0004
477 HYPOMAGNESAEMIA 5 0.0004
478 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
479 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
480 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
481 CHOLECYSTITIS ACUTE 2 0.0004
482 SINUS TACHYCARDIA 5 0.0004
483 MULTI-ORGAN FAILURE 6 0.0003
484 COMA SCALE ABNORMAL 1 0.0003
485 METABOLIC DISORDER 2 0.0003
486 VASCULITIS 4 0.0003
487 GASTROINTESTINAL NECROSIS 1 0.0003
488 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
489 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
490 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
491 CATARACT OPERATION 2 0.0003
492 PULMONARY OEDEMA 15 0.0003
493 POLYNEUROPATHY 4 0.0003
494 HEPATITIS CHOLESTATIC 2 0.0003
495 LEUKOCYTOSIS 6 0.0003
496 STOMATITIS 20 0.0003
497 UNDERDOSE 24 0.0003
498 CYTOPENIA 4 0.0003
499 INTRACARDIAC THROMBUS 1 0.0003
500 LARYNGEAL OEDEMA 2 0.0003
501 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
502 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
503 CHOLANGITIS 2 0.0003
504 VOMITING 151 0.0003
505 HEPATITIS B REACTIVATION 1 0.0003
506 HAEMOGLOBIN DECREASED 32 0.0003
507 LIVER ABSCESS 1 0.0003
508 HEPATITIS ACUTE 2 0.0003
509 HYPOVENTILATION 1 0.0003
510 HEPATIC NEOPLASM 1 0.0003
511 PULMONARY CONGESTION 4 0.0003
512 OTITIS MEDIA 1 0.0003
513 PEPTIC ULCER 1 0.0003
514 PYREXIA 103 0.0003
515 PERICARDITIS 5 0.0003
516 RENAL IMPAIRMENT 25 0.0003
517 DYSARTHRIA 11 0.0003
518 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
519 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
520 LYMPHOEDEMA 2 0.0003
521 DERMATITIS 6 0.0003
522 ASTHENIA 107 0.0003
523 NECROTISING FASCIITIS 1 0.0003
524 RENAL FAILURE ACUTE 12 0.0003
525 FACIAL PARESIS 1 0.0003
526 FIBRIN D DIMER INCREASED 1 0.0003
527 RENAL DISORDER 13 0.0003
528 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
529 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
530 HEPATITIS 7 0.0003
531 AMYLASE INCREASED 1 0.0003
532 HYPERTENSIVE CRISIS 3 0.0003
533 CARDIAC DYSFUNCTION 1 0.0003
534 RETINOPATHY 1 0.0003
535 HYDRONEPHROSIS 2 0.0003
536 BLOOD SODIUM DECREASED 5 0.0003
537 LUNG DISORDER 13 0.0003
538 CATHETER SITE INFECTION 1 0.0003
539 LIPASE INCREASED 2 0.0003
540 NAUSEA 206 0.0003
541 OESOPHAGEAL ULCER 1 0.0003
542 CARDIOPULMONARY FAILURE 1 0.0003
543 SKIN ODOUR ABNORMAL 1 0.0003
544 OESOPHAGEAL PAIN 1 0.0003
545 CEREBRAL ATROPHY 1 0.0003
546 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
547 DECREASED APPETITE 58 0.0002
548 BLOOD DISORDER 2 0.0002
549 ATRIAL FIBRILLATION 24 0.0002
550 SHOCK HAEMORRHAGIC 2 0.0002
551 RECURRENT CANCER 1 0.0002
552 PERIPHERAL ISCHAEMIA 1 0.0002
553 ARTHRITIS BACTERIAL 1 0.0002
554 PRODUCT PREPARATION ERROR 5 0.0002
555 INJECTION SITE EXTRAVASATION 3 0.0002
556 OSTEONECROSIS OF JAW 6 0.0002
557 ACUTE CORONARY SYNDROME 2 0.0002
558 GASTROINTESTINAL PERFORATION 1 0.0002
559 INFUSION SITE ERYTHEMA 2 0.0002
560 CANDIDA INFECTION 4 0.0002
561 MUSCLE FATIGUE 1 0.0002
562 HEPATIC LESION 1 0.0002
563 PYELONEPHRITIS 2 0.0002
564 OCULAR ICTERUS 1 0.0002
565 HYPERKALAEMIA 8 0.0002
566 ADVERSE EVENT 21 0.0002
567 HYPOXIA 8 0.0002
568 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
569 BLOOD CREATINE INCREASED 1 0.0002
570 DEHYDRATION 30 0.0002
571 BRAIN NEOPLASM MALIGNANT 1 0.0002
572 MYALGIA 38 0.0002
573 PULMONARY EMBOLISM 21 0.0002
574 NEUROPATHY PERIPHERAL 21 0.0002
575 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
576 EAR DISORDER 1 0.0002
577 UROSEPSIS 2 0.0002
578 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
579 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
580 PERICARDIAL EFFUSION 5 0.0002
581 LOCALISED OEDEMA 1 0.0002
582 INTERCEPTED MEDICATION ERROR 1 0.0002
583 DEVICE OCCLUSION 3 0.0002
584 HEPATIC CIRRHOSIS 4 0.0002
585 PNEUMONIA 68 0.0002
586 PRODUCT PRESCRIBING ERROR 5 0.0002
587 IMPAIRED QUALITY OF LIFE 3 0.0002
588 OEDEMA PERIPHERAL 25 0.0002
589 HAEMORRHOIDS 4 0.0002
590 HAEMATURIA 7 0.0002
591 HEPATOMEGALY 2 0.0002
592 OEDEMA 11 0.0002
593 DRUG INTERACTION 32 0.0002
594 INJECTION SITE INFLAMMATION 1 0.0002
595 TOXIC SKIN ERUPTION 2 0.0002
596 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
597 FEMORAL NECK FRACTURE 1 0.0002
598 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
599 CACHEXIA 1 0.0002
600 FAILURE TO THRIVE 1 0.0002
601 CONSTIPATION 42 0.0002
602 APLASTIC ANAEMIA 1 0.0002
603 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
604 RETCHING 4 0.0002
605 ANAL FISSURE 1 0.0002
606 GINGIVITIS 1 0.0002
607 ABDOMINAL PAIN 43 0.0002
608 FAECALOMA 1 0.0002
609 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
610 GASTRIC ULCER HAEMORRHAGE 1 0.0002
611 COAGULOPATHY 3 0.0002
612 NECROSIS 1 0.0002
613 INTRACRANIAL PRESSURE INCREASED 1 0.0002
614 PANCREATITIS ACUTE 4 0.0002
615 MITRAL VALVE INCOMPETENCE 2 0.0002
616 PERONEAL NERVE PALSY 1 0.0002
617 OFF LABEL USE 154 0.0002
618 CARDIAC FAILURE CONGESTIVE 14 0.0002
619 BLOOD URIC ACID INCREASED 1 0.0002
620 UNINTENTIONAL MEDICAL DEVICE REMOVAL 2 0.0002
621 HYPERVENTILATION 1 0.0002
622 CARDIAC PACEMAKER INSERTION 1 0.0002
623 PROTHROMBIN TIME PROLONGED 1 0.0002
624 RESPIRATORY DISORDER 5 0.0002
625 TOXICITY TO VARIOUS AGENTS 28 0.0002
626 NO THERAPEUTIC RESPONSE 2 0.0002
627 EPILEPSY 5 0.0002
628 SCOLIOSIS 1 0.0002
629 PHARYNGITIS 2 0.0002
630 HEPATIC STEATOSIS 3 0.0002
631 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
632 HAEMOGLOBIN ABNORMAL 1 0.0002
633 INFUSION SITE PAIN 2 0.0002
634 PRODUCT USE ISSUE 29 0.0002
635 PRODUCT USE IN UNAPPROVED INDICATION 38 0.0002
636 INFECTION 22 0.0002
637 CORONAVIRUS INFECTION 1 0.0002
638 CYTOKINE RELEASE SYNDROME 3 0.0001
639 THERAPEUTIC RESPONSE DECREASED 9 0.0001
640 ARRHYTHMIA 7 0.0001
641 PRODUCT LABEL ISSUE 1 0.0001
642 DRUG TOXICITY 2 0.0001
643 MOOD ALTERED 4 0.0001
644 ONYCHOCLASIS 1 0.0001
645 RESPIRATORY DISTRESS 4 0.0001
646 TREATMENT FAILURE 12 0.0001
647 ANAPHYLACTIC REACTION 8 0.0001
648 HAIR GROWTH ABNORMAL 1 0.0001
649 PULMONARY HYPERTENSION 3 0.0001
650 LARGE INTESTINE PERFORATION 1 0.0001
651 RIGHT VENTRICULAR FAILURE 1 0.0001
652 DEVICE MALFUNCTION 10 0.0001
653 DUODENAL ULCER 1 0.0001
654 PULMONARY TOXICITY 1 0.0001
655 DIALYSIS 2 0.0001
656 METASTASIS 1 0.0001
657 HYPOTENSION 28 0.0001
658 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
659 FAECES DISCOLOURED 3 0.0001
660 DERMATITIS BULLOUS 1 0.0001
661 DIARRHOEA 89 0.0001
662 GASTROENTERITIS 2 0.0001
663 MAJOR DEPRESSION 1 0.0001
664 THROMBOSIS 11 0.0001
665 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
666 CEREBRAL DISORDER 1 0.0001
667 DRUG INTOLERANCE 13 0.0001
668 HAEMORRHAGE INTRACRANIAL 2 0.0001
669 EPISTAXIS 10 0.0001
670 CARDIAC ARREST 11 0.0001
671 PANCREATITIS 7 0.0001
672 HYPERTHERMIA 1 0.0001
673 FEELING HOT 8 0.0001
674 SHOCK 3 0.0001
675 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
676 PROCEDURAL COMPLICATION 1 0.0001
677 FATIGUE 101 0.0001
678 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
679 APHTHOUS ULCER 1 0.0001
680 PULMONARY HAEMORRHAGE 1 0.0001
681 CYANOSIS 2 0.0001
682 FURUNCLE 1 0.0001
683 GINGIVAL PAIN 1 0.0001
684 RHINITIS 1 0.0001
685 MYASTHENIA GRAVIS 1 0.0001
686 PRESYNCOPE 3 0.0001
687 BLOOD POTASSIUM INCREASED 2 0.0001
688 METASTASES TO BONE 2 0.0001
689 VENTRICULAR TACHYCARDIA 2 0.0001
690 CELLULITIS 6 0.0001
691 FACE OEDEMA 2 0.0001
692 DYSPNOEA 67 0.0001
693 CARDIOVASCULAR DISORDER 3 0.0001
694 INADEQUATE ANALGESIA 1 0.0001
695 FACIAL PARALYSIS 1 0.0001
696 URINARY TRACT INFECTION 20 0.0001
697 PSEUDOMONAS INFECTION 1 0.0001
698 BLOOD MAGNESIUM DECREASED 1 0.0001
699 SKIN SWELLING 1 0.0001
700 RESPIRATORY TRACT INFECTION 3 0.0001
701 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
702 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
703 GASTRITIS 3 0.0001
704 IMMUNOSUPPRESSION 1 0.0001
705 ISCHAEMIC STROKE 2 0.0001
706 JAUNDICE 3 0.0001
707 PAIN OF SKIN 3 0.0001
708 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
709 ANAL INCONTINENCE 1 0.0001
710 OROPHARYNGEAL DISCOMFORT 1 0.0001
711 PNEUMONIA BACTERIAL 1 0.0001
712 RETINAL DETACHMENT 1 0.0001
713 DEEP VEIN THROMBOSIS 7 0.0001
714 ERYTHEMA MULTIFORME 1 0.0001
715 LEUKAEMIA 1 0.0001
716 INFUSION RELATED REACTION 7 0.0001
717 COLITIS 4 0.0001
718 PRODUCT PACKAGING ISSUE 1 0.0001
719 PROTEINURIA 2 0.0001
720 MUSCULOSKELETAL DISORDER 2 0.0001
721 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
722 SINUS BRADYCARDIA 1 0.0001
723 BODY TEMPERATURE DECREASED 1 0.0001
724 CEREBROVASCULAR ACCIDENT 17 0.0001
725 PRODUCT ADMINISTRATION ERROR 2 0.0001
726 MOTOR DYSFUNCTION 1 0.0001
727 INITIAL INSOMNIA 1 0.0001
728 EAR DISCOMFORT 1 0.0001
729 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
730 NERVOUS SYSTEM DISORDER 3 0.0001
731 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
732 FOLLICULITIS 1 0.0001
733 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
734 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
735 PHARYNGITIS STREPTOCOCCAL 1 0.0001
736 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
737 PULMONARY THROMBOSIS 1 0.0001
738 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
739 EYE DISORDER 3 0.0001
740 GASTROINTESTINAL PAIN 1 0.0001
741 TACHYCARDIA 8 0.0001
742 SKIN DISORDER 3 0.0001
743 RASH MACULO-PAPULAR 2 0.0001
744 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
745 MALNUTRITION 1 0.0001
746 SKIN INFECTION 1 0.0001
747 INTESTINAL PERFORATION 1 0.0001
748 NEPHROPATHY TOXIC 1 0.0001
749 BLISTER 5 0.0001
750 BLOOD CALCIUM DECREASED 1 0.0001
751 NEOPLASM 1 0.0001
752 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
753 GASTRIC HAEMORRHAGE 1 0.0001
754 ALOPECIA 17 0.0001
755 ELECTROLYTE IMBALANCE 1 0.0001
756 POST PROCEDURAL HAEMORRHAGE 1 0.0001
757 CARDIAC DISORDER 8 0.0001
758 HYPERTENSION 18 0.0001
759 LYMPHADENOPATHY 3 0.0001
760 DRUG DOSE OMISSION 14 0.0001
761 ATAXIA 1 0.0001
762 MUSCLE RIGIDITY 1 0.0001
763 HEPATITIS C 1 0.0001
764 HYPERGLYCAEMIA 3 0.0001
765 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
766 HYPERCALCAEMIA 1 0.0001
767 DYSGEUSIA 6 0.0001
768 HEART RATE INCREASED 8 0.0001
769 INFLUENZA 9 0.0001
770 CYST 1 0.0001
771 DRUG INEFFECTIVE 106 0.0001
772 PNEUMONIA ASPIRATION 2 0.0001
773 CHRONIC KIDNEY DISEASE 6 0.0001
774 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
775 MALAISE 34 0.0001
776 SKIN ULCER 2 0.0001
777 PLATELET COUNT INCREASED 1 0.0001
778 DEATH 66 0.0001
779 DEAFNESS 2 0.0001
780 INCORRECT PRODUCT STORAGE 1 0.0001
781 ORAL CANDIDIASIS 1 0.0001
782 IMMUNE SYSTEM DISORDER 1 0.0001
783 SARS-COV-2 TEST POSITIVE 1 0.0001
784 HYPERSENSITIVITY 14 0.0001
785 QUALITY OF LIFE DECREASED 1 0.0001
786 IMPAIRED GASTRIC EMPTYING 1 0.0001
787 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
788 HAEMOPTYSIS 2 0.0001
789 MASS 1 0.0001
790 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
791 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
792 RED BLOOD CELL COUNT DECREASED 2 0.0001
793 PARALYSIS 1 0.0001
794 RECTAL HAEMORRHAGE 3 0.0001
795 HYPERTHYROIDISM 1 0.0001
796 HYPOKINESIA 1 0.0001
797 FLUID OVERLOAD 1 0.0001
798 NEEDLE ISSUE 2 0.0001
799 DYSPHONIA 4 0.0001
800 CONFUSIONAL STATE 11 0.0001
801 COLON CANCER 1 0.0001
802 ADVERSE DRUG REACTION 6 0.0001
803 THERAPY NON-RESPONDER 3 0.0001
804 VERTIGO 4 0.0001
805 INSURANCE ISSUE 1 0.0001
806 DEVICE ADHESION ISSUE 1 0.0001
807 DRUG ADMINISTRATION ERROR 2 0.0001
808 CHEST PAIN 12 0.0001
809 SOMNOLENCE 13 0.0001
810 PARAESTHESIA 10 0.0001
811 SCIATICA 1 0.0001
812 MUSCULAR WEAKNESS 7 0.0001
813 PRODUCT DOSE OMISSION 4 0.0001
814 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
815 EXPIRED PRODUCT ADMINISTERED 2 0.0001
816 SYNCOPE 6 0.0001
817 URINARY RETENTION 2 0.0001
818 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
819 HEMIPARESIS 1 0.0001
820 CIRCULATORY COLLAPSE 1 0.0001
821 METRORRHAGIA 1 0.0001
822 CHEST DISCOMFORT 6 0.0001
823 SCAR 1 0.0001
824 ERYTHEMA 12 0.0001
825 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
826 ABDOMINAL PAIN UPPER 12 0.0001
827 DELIRIUM 2 0.0001
828 HAEMORRHAGE 6 0.0001
829 DEVICE USE ISSUE 1 0.0001
830 BRADYCARDIA 3 0.0001
831 OSTEOMYELITIS 1 0.0001
832 MUSCLE SPASMS 10 0.0001
833 MEDICATION ERROR 3 0.0001
834 BACTERIAL INFECTION 1 0.0001
835 COUGH 15 0.0001
836 SWELLING 5 0.0001
837 PHOTOPHOBIA 1 0.0001
838 DYSPNOEA EXERTIONAL 2 0.0001
839 FRACTURE 1 0.0001
840 DIABETES MELLITUS 4 0.0001
841 BLOOD PRESSURE INCREASED 8 0.0001
842 HERPES ZOSTER 3 0.0001
843 PULMONARY FIBROSIS 1 0.0001
844 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
845 ERUCTATION 1 0.0001
846 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
847 CHOKING 1 0.0001
848 BONE PAIN 3 0.0001
849 KIDNEY INFECTION 1 0.0001
850 DYSPEPSIA 5 0.0001
851 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
852 SINUS DISORDER 1 0.0001
853 FULL BLOOD COUNT DECREASED 1 0.0000
854 BODY TEMPERATURE INCREASED 1 0.0000
855 INFLUENZA LIKE ILLNESS 4 0.0000
856 PERITONITIS 1 0.0000
857 PRODUCT DOSE OMISSION ISSUE 14 0.0000
858 MOUTH ULCERATION 1 0.0000
859 POOR QUALITY SLEEP 1 0.0000
860 DEVICE LEAKAGE 2 0.0000
861 PRODUCT PRESCRIBING ISSUE 1 0.0000
862 APPLICATION SITE PAIN 1 0.0000
863 NEOPLASM MALIGNANT 3 0.0000
864 ORAL PAIN 1 0.0000
865 GASTROINTESTINAL DISORDER 4 0.0000
866 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
867 CHROMATURIA 1 0.0000
868 TINNITUS 2 0.0000
869 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
870 BURNING SENSATION 3 0.0000
871 DYSPHAGIA 4 0.0000
872 CEREBRAL INFARCTION 1 0.0000
873 MYOCARDIAL INFARCTION 7 0.0000
874 HOT FLUSH 3 0.0000
875 ABDOMINAL PAIN LOWER 1 0.0000
876 HYPOPHAGIA 1 0.0000
877 HOSPITALISATION 6 0.0000
878 THERAPY CESSATION 2 0.0000
879 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
880 ANAPHYLACTIC SHOCK 1 0.0000
881 BACK PAIN 9 0.0000
882 RASH GENERALISED 1 0.0000
883 HAEMATOMA 1 0.0000
884 DIPLOPIA 1 0.0000
885 ABDOMINAL DISTENSION 4 0.0000
886 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
887 PALLOR 1 0.0000
888 TREATMENT NONCOMPLIANCE 2 0.0000
889 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
890 SKIN LESION 1 0.0000
891 RESPIRATORY ARREST 1 0.0000
892 MENTAL STATUS CHANGES 1 0.0000
893 FEELING COLD 1 0.0000
894 WEIGHT DECREASED 10 0.0000
895 ABDOMINAL DISCOMFORT 6 0.0000
896 EYE PAIN 2 0.0000
897 FLATULENCE 2 0.0000
898 ANGINA PECTORIS 1 0.0000
899 HYPERSOMNIA 1 0.0000
900 PRODUCT SUBSTITUTION ISSUE 2 0.0000
901 PALPITATIONS 4 0.0000
902 CHILLS 4 0.0000
903 SURGERY 2 0.0000
904 LABORATORY TEST ABNORMAL 1 0.0000
905 RENAL INJURY 1 0.0000
906 DEVICE ISSUE 3 0.0000
907 APHASIA 1 0.0000
908 SUICIDE ATTEMPT 2 0.0000
909 DISCOMFORT 2 0.0000
910 LIMB DISCOMFORT 1 0.0000
911 VISUAL IMPAIRMENT 4 0.0000
912 INJECTION SITE ERYTHEMA 4 0.0000
913 HYPOTHYROIDISM 1 0.0000
914 METABOLIC ACIDOSIS 1 0.0000
915 WEIGHT INCREASED 7 0.0000
916 HIP FRACTURE 1 0.0000
917 NIGHT SWEATS 1 0.0000
918 RHINORRHOEA 2 0.0000
919 PAIN 19 0.0000
920 SWELLING FACE 2 0.0000
921 HEADACHE 19 0.0000
922 RASH 13 0.0000
923 CONDITION AGGRAVATED 9 0.0000
924 PRODUCT QUALITY ISSUE 4 0.0000
925 SINUSITIS 3 0.0000
926 GASTRIC DISORDER 1 0.0000
927 DEVICE USE ERROR 1 0.0000
928 THERAPY INTERRUPTED 2 0.0000
929 CEREBRAL HAEMORRHAGE 1 0.0000
930 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
931 C-REACTIVE PROTEIN INCREASED 1 0.0000
932 ACCIDENTAL OVERDOSE 1 0.0000
933 PAIN IN EXTREMITY 8 0.0000
934 INJECTION SITE MASS 1 0.0000
935 HALLUCINATION 2 0.0000
936 SEIZURE 3 0.0000
937 PERIPHERAL SWELLING 4 0.0000
938 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
939 DEVICE BREAKAGE 1 0.0000
940 LUNG NEOPLASM MALIGNANT 1 0.0000
941 DIZZINESS 12 0.0000
942 LOSS OF CONSCIOUSNESS 3 0.0000
943 HYPERHIDROSIS 3 0.0000
944 HYPOACUSIS 1 0.0000
945 DEVICE DISLOCATION 1 0.0000
946 MENTAL DISORDER 1 0.0000
947 PRODUCT STORAGE ERROR 2 0.0000
948 DRY SKIN 3 0.0000
949 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
950 INCORRECT DOSE ADMINISTERED 5 0.0000
951 COGNITIVE DISORDER 1 0.0000
952 RENAL CANCER 1 0.0000
953 PRODUCTIVE COUGH 1 0.0000
954 MULTIPLE SCLEROSIS 1 0.0000
955 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
956 FLUID RETENTION 1 0.0000
957 ILLNESS 2 0.0000
958 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
959 INFLAMMATION 1 0.0000
960 MUSCULOSKELETAL PAIN 1 0.0000
961 DEPRESSED MOOD 1 0.0000
962 INSOMNIA 5 0.0000
963 DRUG EFFECT DECREASED 1 0.0000
964 DISTURBANCE IN ATTENTION 1 0.0000
965 OVERDOSE 4 0.0000
966 HAEMATOCHEZIA 1 0.0000
967 DEPRESSION 4 0.0000
968 LETHARGY 1 0.0000
969 ILL-DEFINED DISORDER 1 0.0000
970 VISION BLURRED 2 0.0000
971 MEMORY IMPAIRMENT 2 0.0000
972 SLEEP DISORDER 1 0.0000
973 ANXIETY 4 0.0000
974 MOBILITY DECREASED 1 0.0000
975 AGITATION 1 0.0000
976 INJECTION SITE SWELLING 1 0.0000
977 SKIN EXFOLIATION 1 0.0000
978 INTENTIONAL PRODUCT MISUSE 1 0.0000
979 MUSCULOSKELETAL STIFFNESS 1 0.0000
980 NASOPHARYNGITIS 2 0.0000
981 BLOOD GLUCOSE INCREASED 2 0.0000
982 MIGRAINE 1 0.0000
983 GAIT DISTURBANCE 2 0.0000
984 PRURITUS 4 0.0000
985 FLUSHING 1 0.0000
986 FALL 3 0.0000
987 JOINT SWELLING 1 0.0000
988 HYPOAESTHESIA 1 0.0000
989 INJECTION SITE PAIN 2 0.0000
990 ARTHRALGIA 2 0.0000
991 FEELING ABNORMAL 1 0.0000